| Literature DB >> 33251108 |
Abhradeep Majumder1, Ashok Kumar Gupta2, Partha Sarathi Ghosal3, Mahesh Varma2.
Abstract
The hospital wastewater imposes a potent threat to the security of human health concerning its high vulnerability towards the outbreak of several diseases. Furthermore, the outbreak of COVID-19 pandemic demanded a global attention towards monitoring viruses and other infectious pathogens in hospital wastewater and their removal. Apart from that, the presence of various recalcitrant organics, pharmaceutically active compounds (PhACs), etc. imparts a complex pollution load to water resources and ecosystem. In this review, an insight into the occurrence, persistence and removal of drug-resistant microorganisms and infectious viruses as well as other micro-pollutants have been documented. The performance of various pilot/full-scale studies have been evaluated in terms of removal of biochemical oxygen demand (BOD), chemical oxygen demand (COD), total suspended solids (TSS), PhACs, pathogens, etc. It was found that many biological processes, such as membrane bioreactor, activated sludge process, constructed wetlands, etc. provided more than 80% removal of BOD, COD, TSS, etc. However, the removal of several recalcitrant organic pollutants are less responsive to those processes and demands the application of tertiary treatments, such as adsorption, ozone treatment, UV treatment, etc. Antibiotic-resistant microorganisms, viruses were found to be persistent even after the treatment of hospital wastewater, and high dose of chlorination or UV treatment was required to inactivate them. This article circumscribes the various emerging technologies, which have been used to treat PhACs and pathogens. The present review also emphasized the global concern of the presence of SARS-CoV-2 RNA in hospital wastewater and its removal by the existing treatment facilities.Entities:
Keywords: Advanced oxidation processes; Antibiotic-resistant bacteria; Antibiotic-resistant genes; Biological processes; Pharmaceutically active compounds; SARS-CoV-2 RNA
Year: 2020 PMID: 33251108 PMCID: PMC7680650 DOI: 10.1016/j.jece.2020.104812
Source DB: PubMed Journal: J Environ Chem Eng ISSN: 2213-2929
Number of in-house patients and wastewater generated daily by different hospitals across the world.
| Countries | Number of Patients | Wastewater generated (m3/d) | Wastewater generated per patient (L/patient/day) | References |
|---|---|---|---|---|
| Italy | 300 | 180 | 600 | |
| Germany | 560 | 111 | 198 | |
| Spain | 750 | 429 | 572 | |
| Portugal | 1120 | 1000 | 892 | |
| Brazil | 432 | |||
| Brazil | 325.7 | |||
| Iran | 43 | |||
| Denmark | 691 | 360 | 520 | |
| Germany | 340 | 768 | 2258 | |
| Germany | 580 | 200 | 344 | |
| Netherlands | 1076 | 240 | 223 | |
| Ethiopia | 305 | 143 | 468 | |
| India | 319 | 50 | 156 | |
| India | 480 | |||
| Nepal | 20 | |||
| China | 20 | |||
| Brazil | 190 | |||
| Brazil | 2000 | 219 | 109 | |
| Brazil | 22,000 | 432 | 19 | |
| Brazil | 320 | 220 | 687 | |
| USA | 968 | |||
| Ghana | 31 | |||
| Ghana | 54 |
Fig. 1Characteristics of hospital wastewater: a) range of COD, BOD, ammonia, TSS, nitrate, TOC, TKN, TN b) variation of average concentration of COD, BOD, ammonia, TSS, nitrate, TOC, TKN, TN in different continents, c) range of pharmaceutically active compounds, and d) variation of average concentration of pharmaceutically active compounds in different continents.
Fig. 2a) The BOD/COD ratio of effluents from various hospitals, b) correlation between percentage of population affected by COVID-19 and percentage of positive samples of SARS-CoV-2 RNA in water of different countries
Fig. 3Pathways of pharmaceutically active compounds, antibiotic-resistant microorganisms and viruses in hospital wastewater.
Details of various pilot-scale and full-scale studies for remediation of hospital wastewater.
| Study number | Country | Treatment Description | Flow | HRT | SRT | Plant type | References |
|---|---|---|---|---|---|---|---|
| Study 1 | Belgium | A transportable pilot-scale subsurface flow CW (1 m3). The cubic tank was filled with a 80 cm layer of coarse Rhine gravel (8–16 mm, porosity = 40%, Macrophyte- | 200 L/day | 2 d | Pilot-scale | ||
| Study 2 | Brazil | UASB followed by 3 serial anaerobic filters | 2.54 L/s | 8 h | Full-scale | ||
| Study 3 | Brazil | ASP with extended aeration followed by chlorination | 5 L/s | 18 h | Full-scale | ||
| Study 4 | China | MBR: 6 m3 had 2 equal parts separated by a plate. 1 hollow fiber membrane module set was submerged in each part of the reactor. Each set consisted of 24 membrane modules, total membrane area = 96 m2 | 20 m3/day | 7.2 h | 180 d | Full-scale | |
| Study 5 | China | Conventional ASP (aeration) | 480 m3/day | 35 d | Full-scale | ||
| Study 6 | China | Conventional ASP (aeration) | 200 m3/day | Full-scale | |||
| Study 7 | Denmark | MBBR consisted of three identical reactors of 3 L in series (M1, M2 and M3) each containing 500 AnoxKaldnes™ K5 carriers (AnoxKaldnes, Lund, Sweden), Filling ratio = 50%. The mixing was performed by aeration, Flow =. Retention time | 0.50 L/h | 6 h for each reactor | Pilot-scale | ||
| Study 8 | Denmark | MBBR comprised of six reactors- M1 (900 L for BOD removal and denitrifying), M2 (900 L for nitrifying), M3A (900 L for nitrifying), M3B (900 L for nitrifying), M4 (500 L for denitrifying) and M5 (500 L for nitrifying), respectively. Filling ratio of 50% with 150,000 and 80,000 Anox K™5 carriers (AnoxKaldnes, Lund, Sweden) in the 900 L and 500 L reactors, respectively. | M1, M2, M3A, M3B = 800 L/h, M4, M5 = 300 L/h | M1, M2, M3A, M3B = 1.13 h, M4, M5 = 1.67 h | Pilot-scale | ||
| Study 9 | Denmark | MBR followed by 450 mg/L of PAC | 2.2 m3/day | 35 d | Pilot-scale | ||
| Study 10 | Denmark | MBR | 2.2.m3/day | 35 d | Pilot-scale | ||
| Study 11 | Ethiopia | Waste Stabilization Ponds: 2 facultative ponds (667 m2), 2 maturation ponds (401 m2, 396 m2), and 1 fish pond (862 m2) | 29 d | Full-scale | |||
| Study 12 | Ethiopia | 8 horizontal subsurface flow CWs (4 m length, 1.2 m width and 0.6 m depth) with gravel and broken brick media as substrate. | 165.75 L/day | 4 d | Pilot-scale | ||
| Study 13 | Finland | Ultrafiltration followed by pulsed corona discharge (30 W was applied for 1 kWh /m3 of pulse energy delivered) | Pilot-scale | ||||
| Study 14 | Spain | MBR (11 m3) with 10 flat sheet (FS) chloral polyethylene membranes (0.8 m2 each). Coarse bubble aeration was provided, MLSS- 8 g/L | 100 L/h | 50 h | 30 d | ||
| Study 15 | France | Activated sludge incorporated with biofilms followed by ultrafiltration, Dissolved oxygen: 1–4.5 mg/L | 100 L/day | 22 h | 20 d | ||
| Study 16 | Germany | The unit comprised of a MBR: Membrane area per module = 320 m2, Total membrane area = 1600 m2 | 130 m3/day | 31.3 h | Pilot-scale | ||
| Study 17 | Germany | MBR comprising of Mesh, primary settling tank (21 m3: HRT= 1 h), Oxic/anaerobic chamber (56 m3, suspended solid concentration= 10–12 g/L), microfiltration (102 m3) followed by NF/RO | 130 m3/day | Pilot-scale | |||
| Study 18 | Greece | Pre-treatment (grit-removal), a mix tank, and a biological secondary treatment- Aeration tank (600 m3) followed by disinfection (chlorine dose 10–20 mg/L) | 6 h | 11 d | Full-scale | ||
| Study 19 | India | Conventional ASP followed by high pressure filtration (26 pounds/cm2) and chlorination (5% hypochlorite- 35 L per 0.3 million L of water. | Pilot-scale | ||||
| Study 20 | India | Horizontal sub surface flow CW (1.5 m length, 0.65 m width and 0.5 m depth) | 10 m3/day | Pilot-scale | |||
| Study 21 | Indonesia | Aerated Fixed Film bio filter Reactor followed by ozone reactor | Pilot-scale | ||||
| Study 22 | Italy | Submerged MBR with UF shallow fiber membranes. biomass content (10–12 kg/m3) | 90 L/h | 14 h | 50 d | Pilot-scale | |
| Study 23 | Iran | 2 sets of cylindrical columns made of Plexiglass were used as MBBR reactors. Packing= 70%, Packing material for column 1- Kaldnes (K1) (Pakan Ghatreh, Iran) Packing material for column 2- lightweight expanded clay aggregate (LECA). Column’s dimension- inside diameter, height, overflow height, total volume, and effective volume were 30 cm, 150 cm, 130 cm, 105 L, and 91 L, respectively. Air was supplied from bottom of the columns using an air, MLSS = 3000 mg/L. | 0.001–0.003 L/s | 24 h | Full-scale | ||
| Study 24 | Iran | ASP (Aerobic and anaerobic zones) | Pilot-scale | ||||
| Study 25 | Korea | Chemical flocculation followed by activated carbon adsorption | Full-scale | ||||
| Study 26 | Luxembourg | MBR followed by UV (10 kW Medium pressure lamp, 1.11 gH2O2/L. | 3.33 m3/day | Pilot-scale | |||
| Study 27 | Nepal | The system consists of a septic tank (16.7 m3), followed by a horizontal flow CW (140 m2) with 0.65–0.75 m depth and a vertical flow CW bed (120 m2) with 1 m depth. | 20 m3/day | Full-scale | |||
| Study 28 | Saudi Arabia | ASP (Aerobic Tank) followed by sand filtration and chlorination process. | 904 m3/day | Full-scale | |||
| Study 29 | Saudi Arabia | ASP (Aeration Tank with 3 blowers) followed by sand filtration and chlorination process. | 622 m3/day | Full-scale | |||
| Study 30 | Switzerland | Primary clarifier followed by MBR ( Chamber 1 is oxic and chamber 2 is anoxic). | 1.2 m3/day | Pilot-scale | |||
| Study 31 | Switzerland | Ozonation- 1.08 gO3/g Dissolved organic carbon | 12–23 L/h | Pilot-scale | |||
| Study 32 | Switzerland | PAC- 23 mg/L | 180 L/day | Pilot-scale | |||
| Study 33 | Switzerland | UV- 2400 J/m2 | 600 L/h | Pilot-Scale | |||
| Study 34 | Switzerland | MBR ( Chamber 1 is oxic and chamber 2 is anoxic) followed by Ozonation- 1.08 gO3/g | Pilot-scale | ||||
| Study 35 | Switzerland | MBR ( Chamber 1 is oxic and chamber 2 is anoxic) followed by PAC- 23 mg/L | Pilot-scale | ||||
| Study 36 | Switzerland | MBR ( Chamber 1 is oxic and chamber 2 is anoxic) followed by UV- 2400 J/m2 | Pilot-scale | ||||
| Study 37 | Thailand | Vertical flow CW (1.5 m length, 0.6 m width and 0.6 m depth), The media bed contained sand, pea gravel and gravel with respective height of 0.1, 0.2, and 0.4 m from top to bottom. | 75–85 L/day | 5 d | Pilot-scale | ||
| Study 38 | Thailand | MBR with aeration supplied at 340 L/min | 500 L/h | 3 h | Pilot-scale | ||
| Study 39 | Vietnam | Physical, chemical treatment followed by ASP | Full-scale | ||||
| Study 40 | Vietnam | ASP followed by filtration | Full-scale |
Fig. 4Performance of pilot-scale and full-scale studies in terms of a) TSS removal b) COD removal, c) BOD removal, d) ammonia removal, and e) PhACs removal from hospital wastewater
Fig. 5Schematic representation of different pilot/full-scale treatment units implemented for removing various pollutants in hospital wastewater generated from different sources.
Fig. 6Chlorine dose required for efficient inactivation of antibiotic-resistant bacteria, antibiotic-resistant genes, viruses and other microorganisms